Email Us Here

NeuroVive and the European Brain Injury Consortium Sign Traumatic Brain Injury Clinical Trial Collaboration

Phase II/III study will determine the safety and efficacy of NeuroSTAT in patients with moderate to severe traumatic brain injury.